AU2001294824A1 - Piperazine based inhibitors of factor xa - Google Patents
Piperazine based inhibitors of factor xaInfo
- Publication number
- AU2001294824A1 AU2001294824A1 AU2001294824A AU9482401A AU2001294824A1 AU 2001294824 A1 AU2001294824 A1 AU 2001294824A1 AU 2001294824 A AU2001294824 A AU 2001294824A AU 9482401 A AU9482401 A AU 9482401A AU 2001294824 A1 AU2001294824 A1 AU 2001294824A1
- Authority
- AU
- Australia
- Prior art keywords
- factor
- based inhibitors
- piperazine based
- piperazine
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23616100P | 2000-09-29 | 2000-09-29 | |
US60/236,161 | 2000-09-29 | ||
PCT/US2001/030315 WO2002026720A2 (en) | 2000-09-29 | 2001-10-01 | PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001294824A1 true AU2001294824A1 (en) | 2002-04-08 |
Family
ID=22888374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001294824A Abandoned AU2001294824A1 (en) | 2000-09-29 | 2001-10-01 | Piperazine based inhibitors of factor xa |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040082786A1 (en) |
EP (1) | EP1322610A2 (en) |
AU (1) | AU2001294824A1 (en) |
WO (1) | WO2002026720A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
US7365205B2 (en) | 2001-06-20 | 2008-04-29 | Daiichi Sankyo Company, Limited | Diamine derivatives |
CN1181065C (en) * | 2002-05-08 | 2004-12-22 | 上海医药工业研究院 | Aralkylformylalkyl piperazine derivative and its application as brain nerve protector |
AU2003284596A1 (en) * | 2002-11-22 | 2004-06-18 | Takeda Pharmaceutical Company Limited | Imidazole derivative, process for producing the same, and use |
PE20040804A1 (en) | 2002-12-19 | 2004-12-31 | Boehringer Ingelheim Pharma | CARBOXAMID DERIVATIVES AS INHIBITORS OF THE Xa FACTOR |
ATE429228T1 (en) * | 2003-02-14 | 2009-05-15 | Serono Lab | DERIVATIVES OF PIPERAZINE-2-CARBOXAMIDE |
WO2005079799A1 (en) * | 2004-02-13 | 2005-09-01 | Glaxo Group Limited | 4-acyl-piperazines as anti-viral agents |
US7371743B2 (en) | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
TWI396686B (en) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | Cyclic amide derivative, and its production and use |
WO2006016237A2 (en) * | 2004-08-04 | 2006-02-16 | Ranbaxy Laboratories Limited | Heterocyclic derivatives as anti-inflammatory agents |
BRPI0515488A (en) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | heterocyclic derivatives and their use as therapeutic agents |
WO2007008145A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
SI2922845T1 (en) | 2012-11-20 | 2018-10-30 | Merial, Inc. | Anthelmintic compounds and compositions and method of using thereof |
BR112015023279B1 (en) | 2013-03-13 | 2021-01-19 | Forma Therapeutics, Inc. | compounds for fasn inhibition |
EP3873214A4 (en) | 2018-10-29 | 2022-07-13 | Forma Therapeutics, Inc. | Solid forms of (4-(2-fluoro-4-(1-methyl-1 h-benzo[d]imidazol-5-yl)benzoyl) piperazin-1-yl)(1-hydroxycyclopropyl)methanone |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2287292A1 (en) * | 1997-05-30 | 1998-12-03 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
ATE314347T1 (en) * | 1997-09-30 | 2006-01-15 | Daiichi Seiyaku Co | SULFONYL DERIVATIVES |
CA2340100A1 (en) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
-
2001
- 2001-10-01 AU AU2001294824A patent/AU2001294824A1/en not_active Abandoned
- 2001-10-01 US US10/381,928 patent/US20040082786A1/en not_active Abandoned
- 2001-10-01 WO PCT/US2001/030315 patent/WO2002026720A2/en not_active Application Discontinuation
- 2001-10-01 EP EP01975505A patent/EP1322610A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002026720A2 (en) | 2002-04-04 |
US20040082786A1 (en) | 2004-04-29 |
EP1322610A2 (en) | 2003-07-02 |
WO2002026720A3 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273040A1 (en) | Factor xa inhibitors | |
AU6762400A (en) | Inhibitors of factor xa | |
AU5723500A (en) | Inhibitors of factor xa | |
AU5283700A (en) | Inhibitors of factor xa | |
AU5283900A (en) | Inhibitors of factor xa | |
AU3857300A (en) | Inhibitors of factor xa | |
AU2001249399A1 (en) | Isoquinolone inhibitors of factor xa | |
IL148698A0 (en) | INHIBITORS OF FACTOR Xa | |
AU2002351179A1 (en) | Glycinamides as factor xa inhibitors | |
AU2001234689A1 (en) | Bivalent phenylene inhibitors of factor xa | |
HRP20040453A2 (en) | Indole-2-carboxamides as factor xa inhibitors | |
AU5283600A (en) | Inhibitors of factor xa | |
AU2002365896A1 (en) | SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS | |
AU2001249397A1 (en) | Oxindole inhibitors of factor xa | |
AU2001294824A1 (en) | Piperazine based inhibitors of factor xa | |
AU2001297648A1 (en) | Substituted carboxamides as inhibitors of factor xa | |
AU2002303264A1 (en) | Fused heterocyclic inhibitors of factor xa | |
IL159195A0 (en) | Pyrrolidine derivatives as factor xa inhibitors | |
IL162454A0 (en) | Pyrrolidine-2-ones as factor xa inhibitors | |
AU2002222933A1 (en) | Inhibitors of factor xa | |
AU2002338734A1 (en) | Use of phosphorodiesterase IV inhibitors | |
PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
AU2002211281A1 (en) | Quaternary amidino based inhibitors of factor xa | |
AU2003296393A1 (en) | Factor xa inhibitors | |
AU2002348501A1 (en) | Factor xa inhibitor |